Meredith Hackel
About
Meredith Hackel is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology.
According to data from OpenAlex, Meredith Hackel has authored 96 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Medicine, 48 papers in Pharmacology and 39 papers in Applied Microbiology and Biotechnology. Recurrent topics in Meredith Hackel's work include Antibiotic Resistance in Bacteria (81 papers), Antibiotics Pharmacokinetics and Efficacy (47 papers) and Antibiotic Use and Resistance (39 papers). Meredith Hackel is often cited by papers focused on Antibiotic Resistance in Bacteria (81 papers), Antibiotics Pharmacokinetics and Efficacy (47 papers) and Antibiotic Use and Resistance (39 papers). Meredith Hackel collaborates with scholars based in United States, Canada and Japan. Meredith Hackel's co-authors include Daniel F. Sahm, James A. Karlowsky, Krystyna M. Kazmierczak, Robert E. Badal, Paul G. Higgins, Yoshinori Yamano, Harald Seifert, Douglas J. Biedenbach, Daryl J. Hoban and Roger Echols and has published in prestigious journals such as Journal of Bacteriology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
In The Last Decade
Meredith Hackel
94 papers receiving 4.3k citations
Hit Papers
Peers
Meredith Hackel
Shazad Mushtaq United Kingdom
Amy J. Mathers United States
Carl Urban United States
D. M. Livermore United Kingdom
Vivì Miriagou Greece
Irene Galani Greece
Francesco Luzzaro Italy
Simona Bratu United States
Kenneth S. Thomson United States
Simone Ambretti Italy
Citations per year, relative to Meredith Hackel Meredith Hackel (= 1×)
peers
Shazad Mushtaq
Countries citing papers authored by Meredith Hackel
Since
Specialization
Citations
This map shows the geographic impact of Meredith Hackel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith Hackel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith Hackel more than expected).
Fields of papers citing papers by Meredith Hackel
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Meredith Hackel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith Hackel. The network helps show where Meredith Hackel may publish in the future.
Co-authorship network of co-authors of Meredith Hackel
This figure shows the co-authorship network connecting the top 25 collaborators of Meredith Hackel. A scholar is included among the top collaborators of Meredith Hackel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meredith Hackel. Meredith Hackel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hackel, Meredith, et al.. (2024). In Vitro Activity of Aztreonam-avibactam and Comparator Agents Against Carbapenemase-producing Enterobacterales Collected in Turkey and the Middle East as Part of the ATLAS Surveillance Program: 2018-2022. Journal of Global Antimicrobial Resistance. 39. 12–12.
2.
Karlowsky, James A., Mark G. Wise, Meredith Hackel, et al.. (2024). Cefepime–taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018–22. Journal of Antimicrobial Chemotherapy. 79(12). 3116–3131.
3.
Wise, Mark G., James A. Karlowsky, Meredith Hackel, et al.. (2023). In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017–2021. Journal of Global Antimicrobial Resistance. 35. 93–100.
4.
Takemura, Miki, Mark G. Wise, Meredith Hackel, Daniel F. Sahm, & Yoshinori Yamano. (2023). In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014–2019). Journal of Antimicrobial Chemotherapy. 78(8). 2019–2027.
5.
Wise, Mark G., James A. Karlowsky, Meredith Hackel, et al.. (2023). In Vitro Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014–2019. Microbial Drug Resistance. 29(8). 360–370.
6.
Kohira, Naoki, Meredith Hackel, Miki Takemura, et al.. (2022). In vitro antibacterial activities of cefiderocol against Gram-negative clinical strains isolated from China in 2020. Journal of Global Antimicrobial Resistance. 32. 181–186.
7.
Stone, Gregory G. & Meredith Hackel. (2022). Antimicrobial activity of ceftazidime-avibactam and comparators against levofloxacin-resistant Escherichia coli collected from four geographic regions, 2012–2018. Annals of Clinical Microbiology and Antimicrobials. 21(1). 13–13.
8.
Takemura, Miki, Krystyna M. Kazmierczak, Meredith Hackel, et al.. (2020). 1252. In Vitro Activity of Cefiderocol Against Metallo-β-Lactamase-Producing Gram-Negative Bacteria Collected in North America and Europe Between 2014 and 2017: SIDERO-WT-2014–2016 Studies. Open Forum Infectious Diseases. 7(Supplement_1). S643–S644.
9.
Karlowsky, James A., Meredith Hackel, Warren Lowman, et al.. (2020). In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE global surveillance programme 2015–2018. Journal of Global Antimicrobial Resistance. 24. 249–256.
10.
Karlowsky, James A., Meredith Hackel, Masakatsu Tsuji, et al.. (2018). In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015. International Journal of Antimicrobial Agents. 53(4). 456–466.
11.
Hackel, Meredith, Masakatsu Tsuji, Yoshinori Yamano, et al.. (2017). In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016. Antimicrobial Agents and Chemotherapy. 62(2).
12.
Hackel, Meredith, Krystyna M. Kazmierczak, Daryl J. Hoban, et al.. (2016). Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014. Antimicrobial Agents and Chemotherapy. 60(8). 4677–4683.
13.
Lob, Sibylle, Robert E. Badal, Meredith Hackel, & Daniel F. Sahm. (2016). Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe—SMART 2011–2014. Journal of the Pediatric Infectious Diseases Society. 6(1). piv109–piv109.
14.
Hastey, Christine J., Audrey N. Schuetz, Karen Anderson, et al.. (2016). Changes in the antibiotic susceptibility of anaerobic bacteria from 2007–2009 to 2010–2012 based on the CLSI methodology. Anaerobe. 42. 27–30.
15.
Lob, Sibylle, Robert E. Badal, Samuel K. Bouchillon, et al.. (2013). Epidemiology and Susceptibility of Gram-Negative Appendicitis Pathogens: SMART 2008–2010. Surgical Infections. 14(2). 203–208.
16.
Badal, Robert E., Samuel K. Bouchillon, Sibylle Lob, et al.. (2013). Etiology, Extended-spectrum β-lactamase Rates and Antimicrobial Susceptibility of Gram-negative Bacilli Causing Intra-abdominal Infections in Patients in General Pediatric and Pediatric Intensive Care Units—Global Data From The Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010. The Pediatric Infectious Disease Journal. 32(6). 636–640.
17.
Peirano, Gisele, Christine Lascols, Meredith Hackel, Daryl J. Hoban, & Johann Pitout. (2013). Molecular epidemiology of Enterobacteriaceae that produce VIMs and IMPs from the SMART surveillance program. Diagnostic Microbiology and Infectious Disease. 78(3). 277–281.
18.
Hawser, Stephen, Samuel K. Bouchillon, Meredith Hackel, Minjun Chen, & Eui-Chong Kim. (2012). Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline Evaluation Surveillance Trial (TEST) 2004–2010. International Journal of Antimicrobial Agents. 39(6). 490–495.
19.
Hoban, Daryl J., Christine Lascols, Lindsay E. Nicolle, et al.. (2012). Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase–producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009–2010. Diagnostic Microbiology and Infectious Disease. 74(1). 62–67.
20.
Higgins, Paul G., et al.. (2009). Global spread of carbapenem-resistant Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 65(2). 233–238.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Shazad Mushtaq Breakdown of academic impact, for papers by Amy J. Mathers Breakdown of academic impact, for papers by Carl Urban Breakdown of academic impact, for papers by D. M. Livermore Breakdown of academic impact, for papers by Vivì Miriagou Breakdown of academic impact, for papers by Irene Galani Breakdown of academic impact, for papers by Francesco Luzzaro Breakdown of academic impact, for papers by Simona Bratu Breakdown of academic impact, for papers by Kenneth S. Thomson Breakdown of academic impact, for papers by Simone Ambretti